SWAV [NASD]
ShockWave Medical, Inc.
Index- P/E254.82 EPS (ttm)0.79 Insider Own1.70% Shs Outstand35.59M Perf Week1.84%
Market Cap6.95B Forward P/E66.81 EPS next Y3.02 Insider Trans-20.92% Shs Float33.73M Perf Month20.85%
Income29.00M PEG- EPS next Q0.53 Inst Own90.60% Short Float4.13% Perf Quarter-3.03%
Sales298.90M P/S23.26 EPS this Y86.90% Inst Trans-2.67% Short Ratio2.13 Perf Half Y13.17%
Book/sh7.53 P/B26.80 EPS next Y47.01% ROA9.00% Target Price193.50 Perf Year7.55%
Cash/sh5.84 P/C34.56 EPS next 5Y- ROE12.40% 52W Range113.36 - 249.73 Perf YTD13.17%
Dividend- P/FCF307.64 EPS past 5Y- ROI-0.50% 52W High-19.18% Beta-
Dividend %- Quick Ratio5.00 Sales past 5Y- Gross Margin84.50% 52W Low78.03% ATR10.74
Employees657 Current Ratio6.10 Sales Q/Q193.40% Oper. Margin10.70% RSI (14)62.54 Volatility5.21% 6.21%
OptionableYes Debt/Eq0.06 EPS Q/Q156.90% Profit Margin9.70% Rel Volume0.84 Prev Close198.62
ShortableYes LT Debt/Eq0.03 EarningsMay 09 AMC Payout0.00% Avg Volume654.71K Price201.82
Recom1.70 SMA2011.10% SMA5019.69% SMA20010.92% Volume550,524 Change1.61%
Apr-06-22Initiated Wolfe Research Outperform $255
Mar-02-22Resumed BofA Securities Buy $200
Dec-06-21Upgrade Wells Fargo Equal Weight → Overweight $235
Jul-15-21Initiated SVB Leerink Outperform $208
Jul-12-21Downgrade BofA Securities Buy → Neutral $180 → $200
Jun-18-21Downgrade Wells Fargo Overweight → Equal Weight $189
May-11-21Upgrade Piper Sandler Neutral → Overweight $134 → $165
May-11-21Upgrade BofA Securities Neutral → Buy $180
Jan-20-21Downgrade Piper Sandler Overweight → Neutral $96 → $132
Dec-01-20Downgrade BofA Securities Buy → Neutral $105
Jun-11-20Upgrade Oppenheimer Underperform → Perform
Apr-01-20Downgrade Oppenheimer Perform → Underperform
Feb-21-20Upgrade BofA/Merrill Neutral → Buy $47 → $50
Dec-12-19Upgrade Wells Fargo Market Perform → Outperform $49
Oct-22-19Initiated Oppenheimer Perform
Oct-21-19Initiated Piper Jaffray Overweight $39
Jun-13-19Reiterated BofA/Merrill Neutral $44 → $64
Apr-01-19Initiated Wells Fargo Market Perform
Apr-01-19Initiated Morgan Stanley Equal-Weight $32
Apr-01-19Initiated BofA/Merrill Neutral $37
Jul-05-22 10:59AM  
10:02AM  
08:16AM  
Jun-29-22 11:17AM  
Jun-28-22 11:29AM  
07:36AM  
Jun-27-22 02:16PM  
08:03AM  
Jun-25-22 08:00AM  
Jun-23-22 11:46AM  
11:45AM  
11:15AM  
Jun-22-22 07:50PM  
07:29AM  
Jun-21-22 09:17AM  
Jun-17-22 08:38AM  
Jun-16-22 09:59AM  
Jun-15-22 08:38AM  
Jun-14-22 04:26PM  
07:44AM  
07:43AM  
Jun-13-22 03:45PM  
03:28PM  
Jun-09-22 12:20PM  
Jun-08-22 11:30AM  
11:08AM  
Jun-06-22 06:41PM  
05:14PM  
10:07AM  
09:50AM  
Jun-05-22 08:44AM  
Jun-03-22 07:21PM  
May-24-22 11:21AM  
05:43AM  
May-23-22 07:30AM  
May-19-22 08:20AM  
07:00AM  
May-12-22 07:10AM  
May-11-22 07:15AM  
May-10-22 02:07AM  
May-09-22 05:25PM  
04:02PM  
May-04-22 05:55PM  
May-02-22 04:00PM  
Apr-27-22 08:00AM  
Apr-22-22 04:25PM  
Apr-19-22 01:38PM  
Apr-15-22 10:53AM  
Apr-12-22 07:35AM  
Apr-05-22 10:22AM  
Apr-01-22 04:17PM  
Mar-31-22 08:30AM  
Mar-30-22 08:30AM  
Mar-22-22 11:32AM  
Mar-08-22 04:05PM  
Feb-21-22 09:56AM  
Feb-18-22 07:02AM  
12:00AM  
Feb-17-22 08:02PM  
05:25PM  
04:05PM  
Feb-11-22 09:34AM  
Feb-10-22 03:01PM  
Feb-04-22 05:38PM  
08:00AM  
07:03AM  
Feb-02-22 09:38AM  
Jan-20-22 05:38PM  
Jan-13-22 11:51PM  
Jan-11-22 04:57AM  
Jan-06-22 10:41AM  
Jan-04-22 04:03PM  
Dec-17-21 08:38PM  
07:38PM  
Dec-16-21 01:01PM  
Dec-12-21 11:47AM  
Dec-10-21 06:38PM  
Dec-09-21 01:38PM  
Dec-01-21 08:58AM  
Nov-22-21 08:05AM  
Nov-17-21 04:03PM  
Nov-11-21 10:48AM  
Nov-09-21 12:01AM  
Nov-08-21 05:15PM  
04:05PM  
Nov-05-21 08:00AM  
Nov-03-21 08:00AM  
Nov-02-21 02:33PM  
Nov-01-21 03:01PM  
Oct-26-21 12:35PM  
Oct-21-21 08:03AM  
Oct-18-21 02:05PM  
Oct-14-21 04:23PM  
Oct-06-21 04:00PM  
12:15PM  
Oct-05-21 04:03PM  
11:28AM  
Oct-01-21 06:25AM  
Sep-07-21 02:18PM  
Sep-06-21 01:24PM  
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zacharias IsaacPresident, CCOJun 27Sale198.004,000792,00078,563Jun 28 08:01 PM
Phung TrinhVP, FinanceJun 23Sale179.356211,12028,563Jun 23 08:05 PM
PUCKETT DANChief Financial OfficerJun 21Option Exercise14.691,35019,83641,288Jun 22 08:03 PM
WATKINS FRANK TDirectorJun 21Sale161.433,000484,28917,802Jun 21 07:12 PM
PUCKETT DANChief Financial OfficerJun 21Sale161.401,350217,89039,938Jun 22 08:03 PM
Godshall Douglas EvanPresident & CEOJun 06Option Exercise3.427,40025,278150,326Jun 08 08:24 PM
Godshall Douglas EvanPresident & CEOJun 06Sale177.327,4001,312,181142,926Jun 08 08:24 PM
Godshall Douglas EvanPresident & CEOMay 27Option Exercise3.422,6008,882145,526Jun 01 07:01 PM
Godshall Douglas EvanPresident & CEOMay 27Sale175.062,600455,156142,926Jun 01 07:01 PM
PUCKETT DANChief Financial OfficerMay 20Option Exercise14.691,35019,83641,288May 27 04:40 PM
PUCKETT DANChief Financial OfficerMay 20Sale161.381,350217,86341,048May 27 04:40 PM
WATKINS FRANK TDirectorMay 20Sale162.983,000488,94520,802May 23 06:24 PM
Godshall Douglas EvanPresident & CEOMay 13Option Exercise3.425,00017,080147,926May 13 08:19 PM
Godshall Douglas EvanPresident & CEOMay 13Sale150.005,000750,000142,926May 13 08:19 PM
Godshall Douglas EvanPresident & CEOMay 11Option Exercise3.4215,00051,240157,926May 12 08:15 PM
Godshall Douglas EvanPresident & CEOMay 11Sale140.8715,0002,113,047142,926May 12 08:15 PM
Zacharias IsaacChief Commercial OfficerApr 29Sale160.3661999,26365,221Apr 29 07:58 PM
Zacharias IsaacChief Commercial OfficerApr 26Sale183.763,370619,27165,840Apr 28 07:32 PM
WATKINS FRANK TDirectorApr 20Sale206.013,000618,02023,802Apr 21 04:17 PM
PUCKETT DANChief Financial OfficerApr 19Option Exercise14.692,70039,67443,629Apr 20 05:21 PM
PUCKETT DANChief Financial OfficerApr 19Sale200.593,691740,38939,938Apr 20 05:21 PM
Phung TrinhVP, FinanceApr 18Sale206.28565116,54828,688Apr 20 04:44 PM
Phung TrinhVP, FinanceApr 12Sale215.613,176684,76329,695Apr 14 05:36 PM
FRANCIS LAURADirectorMar 31Option Exercise6.591,89012,4555,441Mar 31 06:21 PM
FRANCIS LAURADirectorMar 31Sale210.001,890396,9000Mar 31 06:21 PM
FRANCIS LAURADirectorMar 29Option Exercise6.592,31015,2235,861Mar 31 06:21 PM
FRANCIS LAURADirectorMar 29Sale195.332,310451,2060Mar 31 06:21 PM
Zacharias IsaacChief Commercial OfficerMar 28Sale188.834,000755,32069,841Mar 28 04:26 PM
WATKINS FRANK TDirectorMar 21Sale175.183,000525,52726,802Mar 23 04:13 PM
Papiernik AntoineDirectorMar 10Sale163.3860,0009,802,75762,251Mar 11 06:44 PM
PUCKETT DANChief Financial OfficerFeb 23Sale158.762,762438,49541,938Feb 24 07:19 PM
PUCKETT DANChief Financial OfficerFeb 22Option Exercise16.143,82161,66355,228Feb 24 07:19 PM
PUCKETT DANChief Financial OfficerFeb 22Sale144.716,621958,12344,700Feb 24 07:19 PM
WATKINS FRANK TDirectorFeb 22Sale143.863,000431,59329,802Feb 23 09:22 PM
Zacharias IsaacChief Commercial OfficerFeb 15Sale149.964,000599,84077,722Feb 16 07:20 PM
Zacharias IsaacChief Commercial OfficerFeb 02Sale153.631,617248,42080,127Feb 03 04:35 PM
PUCKETT DANChief Financial OfficerJan 20Option Exercise10.521,50015,77246,088Jan 21 06:54 PM
WATKINS FRANK TDirectorJan 20Sale148.413,000445,23032,802Jan 21 06:50 PM
PUCKETT DANChief Financial OfficerJan 20Sale146.491,500219,72844,588Jan 21 06:54 PM
Zacharias IsaacChief Commercial OfficerJan 14Sale175.374,000701,48072,079Jan 18 06:44 PM
WATKINS FRANK TDirectorDec 29Sale176.2520,0003,525,03535,802Dec 30 05:15 PM
Zacharias IsaacChief Commercial OfficerDec 22Option Exercise4.0332,659131,48576,079Dec 23 04:40 PM
PUCKETT DANChief Financial OfficerDec 20Option Exercise17.001,50025,50047,288Dec 21 05:12 PM
PUCKETT DANChief Financial OfficerDec 20Sale168.732,700455,55944,588Dec 21 05:12 PM
Zacharias IsaacChief Commercial OfficerDec 15Sale172.734,000690,92443,420Dec 16 04:50 PM
MOLL FREDERIC HDirectorNov 30Option Exercise0.4912,2956,000291,724Dec 01 05:29 PM
Godshall Douglas EvanPresident & CEONov 18Option Exercise3.4245,000153,720181,856Nov 22 09:00 PM
Godshall Douglas EvanPresident & CEONov 18Sale207.2845,0009,327,660136,856Nov 22 09:00 PM
WATKINS FRANK TDirectorNov 17Sale209.562,000419,12955,802Nov 18 04:58 PM
WATKINS FRANK TDirectorNov 16Sale208.412,000416,82657,802Nov 18 04:58 PM
Zacharias IsaacChief Commercial OfficerNov 15Sale206.164,000824,65847,420Nov 16 05:22 PM
PUCKETT DANChief Financial OfficerNov 01Option Exercise15.702,50039,24548,288Nov 02 05:21 PM
PUCKETT DANChief Financial OfficerNov 01Sale219.722,500549,29045,788Nov 02 05:21 PM
WATKINS FRANK TDirectorOct 20Sale199.602,000399,20859,802Oct 21 05:01 PM
WATKINS FRANK TDirectorOct 19Sale201.372,000402,74761,802Oct 21 05:01 PM
Zacharias IsaacChief Commercial OfficerOct 15Sale194.184,000776,70051,420Oct 18 04:55 PM
PUCKETT DANChief Financial OfficerOct 01Option Exercise15.702,50039,24548,288Oct 04 08:30 PM
PUCKETT DANChief Financial OfficerOct 01Sale195.472,500488,68645,788Oct 04 08:30 PM
WATKINS FRANK TDirectorSep 22Sale222.101,992442,41663,802Sep 23 08:52 PM
WATKINS FRANK TDirectorSep 21Sale216.762,008435,26365,794Sep 23 08:52 PM
Zacharias IsaacChief Commercial OfficerSep 15Sale220.754,000882,98555,420Sep 16 04:26 PM
PUCKETT DANChief Financial OfficerSep 01Option Exercise15.702,50039,24548,288Sep 02 09:28 PM
PUCKETT DANChief Financial OfficerSep 01Sale216.932,500542,33445,788Sep 02 09:28 PM
Godshall Douglas EvanPresident & CEOAug 18Option Exercise3.4245,000153,720181,856Aug 20 05:01 PM
Godshall Douglas EvanPresident & CEOAug 18Sale188.0845,0008,463,465136,856Aug 20 05:01 PM
WATKINS FRANK TDirectorAug 18Sale188.122,000376,23867,802Aug 19 06:21 AM
WATKINS FRANK TDirectorAug 17Sale185.672,000371,34669,802Aug 19 06:21 AM
Zacharias IsaacChief Commercial OfficerAug 16Option Exercise5.074,00020,29963,420Aug 18 06:03 PM
Zacharias IsaacChief Commercial OfficerAug 16Sale186.974,000747,87459,420Aug 18 06:03 PM
PUCKETT DANChief Financial OfficerAug 02Option Exercise13.842,50034,60048,288Aug 04 08:00 PM
PUCKETT DANChief Financial OfficerAug 02Sale176.292,500440,73545,788Aug 04 08:00 PM
WATKINS FRANK TDirectorJul 21Sale174.022,000348,04571,802Jul 22 06:40 PM
WATKINS FRANK TDirectorJul 20Sale170.202,000340,39773,802Jul 21 07:49 PM
Zacharias IsaacChief Commercial OfficerJul 15Option Exercise6.714,00026,84063,420Jul 16 08:18 PM
Zacharias IsaacChief Commercial OfficerJul 15Sale165.494,000661,95859,420Jul 16 08:18 PM